Litcius/Paper detail

Current evidence on the use of anakinra in COVID-19

Elnaz Khani, Marzieh Shahrabi, Haleh Rezaei, Fariba Pourkarim, Hoda Afsharirad, Mohammad Solduzian

2022International Immunopharmacology46 citationsDOIOpen Access PDF

Topics & Concepts

AnakinraMedicineCytokine stormCytokineCoronavirus disease 2019 (COVID-19)Interleukin 1 receptor antagonistImmunologyReceptor antagonistCytokine release syndromeInterleukinDiseaseReceptorAntagonistInternal medicineInfectious disease (medical specialty)Autoimmune and Inflammatory Disorders ResearchKawasaki Disease and Coronary ComplicationsInflammasome and immune disorders
Current evidence on the use of anakinra in COVID-19 | Litcius